Categories: News

Elixxer Ltd. Announces Trading Update

Montreal, Quebec–(Newsfile Corp. – May 12, 2022) – Elixxer Ltd. (the “Corporation” or “Elixxer“) (TSXV: ELXR) (OTCQB: ELXIF) announces that a cease trade order had been issued as a result of its failure to file its year end financial statements within the prescribed filing deadlines. The Corporation is pleased to report that its financial reporting is now up to date and has been advised that the cease trade order issued on May 11th, will be lifted imminently.

About Elixxer Ltd. (www.elixxer.com)

Elixxer is a Canadian public company listed on the TSX Venture Exchange (TSXV: ELXR) and the US OTC-QB exchange (OTCQB: ELIXF).

Through its partners, Elixxer presently has significant interests in Australia, Jamaica, Switzerland, Italy and Canada.

For further information please contact:

Ferras Zalt, Chairman and Interim CEO: ferras@elixxer.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice Regarding Forward-Looking Statements

This press release may contain forward-looking statements with respect to Elixxer and its operations, strategy, investments, financial performance and condition. These statements can generally be identified by use of forward-looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of Elixxer could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in Elixxer’s most recent Management’s Discussion and Analysis filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to Elixxer and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release, and Elixxer has no obligation to update such statements, except to the extent required by applicable securities laws

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/123806

Staff

Recent Posts

NextGen Healthcare Chosen by United Medical Centers to Support Integrated Care Delivery in Communities at United States-Mexico Border

Growing Need for Integration Led FQHC to Select NextGen HealthcareREMOTE-FIRST COMPANY/EAGLE PASS, Texas--(BUSINESS WIRE)--#NextGenHealthcare--Driven by…

56 mins ago

The Assistance Fund Opens New Program for Heart Failure

Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Heart FailureORLANDO,…

57 mins ago

US Med-Equip Earns CIO 100 Award for IT Innovation With New AI Solution Helping Clinicians Secure Medical Equipment on Demand

Life-Saving Equipment Delivered to Patients in Record Time, Lower Cost at Hospitals Using Award-Winning GoUSME…

57 mins ago

Zeto Successfully Completes SOC 2 Type II Audit for Its Cloud Platform, Demonstrating Commitment to Data Security

SANTA CLARA, CA / ACCESSWIRE / March 18, 2024 / Zeto, Inc., a commercial-stage medical…

57 mins ago

Sona Nanotech Announces Filing of Provisional Patent Application

Halifax, Nova Scotia--(Newsfile Corp. - March 18, 2024) - Sona Nanotech Inc. (CSE: SONA), (OTCQB:…

3 hours ago